The on-demand version of the DDW Turning Science into Business Symposium is available to watch now! 

The event, which took place at The Francis Crick Institute on 4 November, features talks covering aspects of drug discovery including AI, oncology, CRISPR, neuroscience and more. 

It also includes a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite the drug discovery process. 

You will hear presentations from: 

  • Dr Daniil Bash, Lead Scientist at the Innovation Centre in Digital Molecular Technologies (iDMT), University of Cambridge 
  • Nikhil Gupta, Principal Scientist, Cancer Research Horizons – AstraZeneca Functional Genomics Centre 
  • Lawrence Welch, Inside Sales Specialist, Nuclera
  • Chas Bountra, Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University 
  • Dr Cathy Tralau-Stewart, Executive Director, The Milner Therapeutics Institute, University of Cambridge 
  • Professor Emma Mead, Chief Scientific Officer, Alzheimer’s Research UK, Oxford Drug Discovery Institute 

The panel discussion featured: 

  • Joanne Taylor, SVP Research, Gain Therapeutics
  • Nadine Clemo, VP Global Program Leader, Apollo Therapeutics
  • Dr Cathy Tralau-Stewart, Executive Director, The Milner Therapeutics Institute, University of Cambridge

The event was sponsored by Nuclera (lead sponsor), Collaborative Drug Discovery (coffee break sponsor) and Thermo Fisher Scientific (sponsor).

The on-demand version of the DDW Turning Science into Business Symposium is only available for a limited time! Register now to watch before December 24th!